Personal care compositions

Information

  • Patent Grant
  • 9622951
  • Patent Number
    9,622,951
  • Date Filed
    Tuesday, October 29, 2013
    10 years ago
  • Date Issued
    Tuesday, April 18, 2017
    7 years ago
Abstract
A personal care composition exhibiting a tan delta of about 0.30 or more at about 10° C. includes a primary surfactant, secondary surfactant, and a polyol. Methods are also provided to improve the stability of a personal care composition.
Description
TECHNICAL FIELD

The present disclosure generally relates to personal care compositions comprising polyols and methods related thereto.


BACKGROUND

The desirability of personal care compositions can be influenced by a variety of factors. For example, consumers are likely to desire personal care compositions that exhibit suitable cleaning and lathering characteristics, are non-drying to the skin, and display favorable rheological properties. Additionally, other factors such as environmental temperature can affect the desirability of the personal care composition as fluctuations in temperature can affect the viscosity and/or elasticity of the personal care composition; potentially impacting the consumer's opinion of whether the personal care composition displays favorable rheological properties. Balancing these qualities can be challenging as the choice of surfactant(s) and other substances in the personal composition can affect one or more or more of these factors. Thus, there is a need in the market for personal care compositions that exhibit suitable cleaning and lathering characteristics, are non-drying to the skin, and display favorable rheological properties.


SUMMARY

A personal care composition comprising a primary surfactant, a secondary surfactant, and a polyol. The primary surfactant comprises an anionic surfactant not sodium lauryl sulfate or ammonium lauryl sulfate. The secondary surfactant comprises a zwitterionic surfactant, an amphoteric surfactant, a non-ionic surfactant, or a combination thereof. The personal care composition exhibits a tan delta of about 0.30 or more at about 10° C.


A personal care composition comprising: a primary surfactant comprising sodium laureth (3) sulfate; a secondary surfactant comprising a zwitterionic surfactant, an amphoteric surfactant, a non-ionic surfactant, or a combination thereof; a viscosity modifier; and sorbitol comprising from about 0.5% to less than 10% by weight of the personal care composition; wherein the personal care composition exhibits a tan delta of about 0.35 or more at about 10° C. and is substantially free of sodium lauryl sulfate.







DETAILED DESCRIPTION

This application claims priority to U.S. provisional application No. 61/719,738 filed Oct. 29, 2012, which is incorporated herein by reference.


While the specification concludes with the claims particularly pointing and distinctly claiming the invention, it is believed that the present invention will be better understood from the following description.


The devices, apparatuses, methods, components, and/or compositions of the present invention can include, consist essentially of, or consist of, the components of the present invention as well as other ingredients described herein.


All percentages and ratios used herein are by weight of the total personal care composition and all measurements made are at 25° C., unless otherwise designated.


All measurements used herein are in metric units unless otherwise specified.


DEFINITIONS

“ALS” refers to ammonium lauryl sulfate.


“CAPB” refers to cocamidopropyl betaine.


“SLS” refers to sodium lauryl sulfate.


“SLES” refers to sodium laureth(n) sulfate.


The term “personal care composition” as used herein, refers to compositions intended for topical application to the skin and/or hair.


The phrase “substantially free of” as used herein, unless otherwise specified means that the personal care composition comprises less than about 2%, less than about 1%, and less than about 0.1% of the stated ingredient. The term “free of” as used herein means that the personal care composition comprise 0% of the stated ingredient that is, the ingredient has not been added to the personal care composition. However, these ingredients may incidentally form as a byproduct or a reaction product of the other components of the personal care composition.


“Stable” refers to a personal care composition having a tan delta greater than about 0.30, about 0.31, about 0.32, about 0.33, about 0.34, or about 0.35 at 10° C. as measured by the method described herein, unless otherwise stated.


Personal Care Compositions


The personal care compositions can be rinse-off formulations that can be applied topically to the skin and/or hair and rinsed from the skin and/or hair within minutes with water. The personal care compositions can exhibit a viscosity of from about 1,000 centipoise (cP) to about 1,000,000 cP, about 1,500 centipoise (cP) to about 1,000,000 cP, from about 5,000 centipoise (cP) to about 1,000,000 cP, from about 6,000 centipoise (cP) to about 1,000,000 cP, or from about 8,000 centipoise (cP) to about 1,000,000 cP, at about 25° C. as measured by the method described herein. The personal care compositions can also be used as shaving aids. The personal care compositions can be extrudable or dispensable from a package. The personal care compositions can be in the form of, for example, a liquid, semi-liquid cream, lotion, or gel and can be intended for topical application to the skin and/or hair. Examples of personal care compositions can include, but are not limited to, shampoo, conditioning shampoo, body wash, moisturizing body wash, shower gels, skin cleansers, cleansing milks, hair and body wash, in shower body moisturizer, pet shampoo, shaving preparations, and cleansing compositions used in conjunction with a disposable cleansing cloth.


The desirability of personal care compositions can be influenced by a variety of factors including the amount and types of surfactants present in the personal care composition. Many consumers use personal care compositions because the personal care compositions can remove dirt, sweat, sebum, and other substances from the skin and/or hair. However, in addition to the cleaning properties displayed by the personal care composition, the desirability of the personal care composition can be also influenced by other factors.


For example, the desirability of a personal care composition can vary depending on the type and amount of the surfactants included in a formulation of a personal care composition. In this regard, a consumer may view a personal care composition as unfavorable when the personal care composition includes surfactants that promote the drying of the skin. Additionally, because many consumers equate cleaning efficiency with the level of foam generated upon using a particular personal care composition, consumers may not desire personal care compositions that include surfactants that do not foam to the level desired. Also potentially impacting the consumers' perception of a personal care composition are the rheological properties displayed by the personal care composition. For example, temperature fluctuations may cause changes in the rheological properties of the personal care composition such that the consumer perceives the product as being too thick and/or indispensable. The balancing of the aforementioned factors while concurrently maintaining the cleaning properties of the personal care composition can be a challenging endeavor.


In addition to the above complexities, some consumers desire a thick product. Thick products can be created by increasing the viscosity of a personal care composition. However, viscosity can be linked to the elastic behavior of the personal care composition, so increasing the viscosity can have negative effects on product feel. One such negative effect is the development of a springy or gel-like character which consumers can dislike.


The rheological behavior of a personal care composition can be characterized by its tan delta. Increasing the viscosity of a personal care composition can lower its tan delta to an unacceptable level, giving the personal care composition an undesired gel-like consistency. Thus, a personal care composition's viscosity and tan delta can be balanced to give the consumer a more acceptable product. For example, a personal care composition with a tan delta above about 0.30, above about 0.31, above about 0.32, above about 0.33, above about 0.34, or above about 0.35 at 10° C. may be perceived by a consumer as having sufficient viscosity to flow over the skin, but not too gel-like or otherwise difficult to spread on the skin or dispense from the package. In contrast, a personal care composition with a tan delta below about 0.30 at 10° C. may be perceived as too gel-like and difficult to spread on the skin and dispense from the container. Additionally, a personal care composition with a thickness below 5000 cP at about 25° C. may be perceived as too thin. In contrast, a personal care composition with a thickness above 5000 cP at about 25° C. may be perceived as having sufficient thickness. The personal care compositions can have a tan delta up to about 20.


A personal care composition's tan delta can fluctuate not only with changes in viscosity, but also across temperature. For example, although a personal care composition may have an acceptable tan delta at room temperature (e.g., 25° C.), the tan delta may be too low at lower temperatures such as at about 10° C. In order to have a composition that can be shipped, stored, and used in all seasons, a tan delta of about 0.30 or more measured at about 10° C. is desired.


It has presently been discovered that the inclusion of certain types of surfactants, like sodium lauryl sulfate (SLS) and other non-ethoxylated alkyl sulfates, can negatively affect the tan delta of a personal care composition at low temperature. Without being limited by theory, this is believed to be due, at least in part, to the degree to which the micelles formed by the surfactant in a personal care composition can compact. SLS is a smaller surfactant molecule and tends to allow for more rigid packing of the micelles. It is believed this more rigid packing can lead to instability of the composition at low temperatures resulting in a lower tan delta. Thus, the stability of a personal care composition at low temperatures can be increased by the removal of SLS from a personal care composition.


Surprisingly, it has also been found that the addition of particular polyols to certain personal care compositions that are free, or substantially free, of SLS can enhance the viscosity and/or improve the rheological properties of certain personal care composition. Surprisingly, it has also been found that even levels of polyols less than about 10% or less by weight of the personal care composition can enhance the viscosity and/or improve the rheological properties of certain personal care compositions free or substantially free of non-ethoxylated alkyl sulfates.


The finding that the addition of particular polyols to certain personal care compositions that are free or substantially free of non-ethoxylated alkyl sulfates can enhance the viscosity and/or improve the rheological properties of the personal care composition is surprising, for example, given the unpredictable nature of polyols in personal care compositions. In this regard, the inclusion of high levels of polyols like glycerin in certain personal care compositions containing sulfosuccinic acid monoester surfactants has been shown to potentially lead to the destabilization of certain personal care compositions.


Primary Surfactants


The personal care composition can comprise a primary surfactant that can comprise an anionic surfactant. The primary surfactant can comprise from about 5% to about 10%, from about 6.4% to about 10%, and from about 6.4% to about 8.4% by weight of the personal care composition. The anionic surfactant can be sodium laureth(n) sulfate, hereinafter SLEnS, wherein n defines the average moles of ethoxylation. The anionic surfactant can also be ammonium laureth(n) sulfate, hereinafter ALEnS, wherein n defines the average moles of ethoxylation. For example, n can range from greater than about 0 to about 3, alternatively from about 0.5 to about 2.7, alternatively from about 1.1 to about 2.5, alternatively from greater than about 0 to about 2.5, alternatively from about 1.8 to about 2.2, or alternatively about 2. It is understood that a material such as SLE3S, for example, may comprise a significant amount of molecules which have no ethoxylate, 1 mole ethoxylate, 4 mole ethoxylate, and so on in a distribution which can be broad, narrow or truncated, while still comprising SLE3S wherein the average of the distribution is about 3. It is understood that a material such as SLE2S, for example, may comprise a significant amount of molecules which have no ethoxylate, 1 mole ethoxylate, 4 mole ethoxylate, and so on in a distribution which can be broad, narrow or truncated, while still comprising SLE2S wherein the average of the distribution is about 2. It is understood that a material such as SLE1S, for example, may comprise a significant amount of molecules which have no ethoxylate, 1 mole ethoxylate, 4 mole ethoxylate, and so on in a distribution which can be broad, narrow or truncated, while still comprising SLE2S wherein the average of the distribution is about 1.


The anionic surfactant can also be sodium trideceth(n) sulfate (hereinafter STnS) and/or ammonium trideceth(n) sulfate (hereinafter ATnS), wherein n defines the average moles of ethoxylation. For example, n can range from greater than 0 to 3, alternatively from 0.5 to 2.7, alternatively from 1.1 to 2.5, alternatively from greater than 0 to 2.5, alternatively from 1.8 to 2.2, alternatively about 2. It is understood that a material such as ST2S, for example, may comprise a significant amount of molecules which have no ethoxylate, 1 mole ethoxylate, 3 mole ethoxylate, and so on in a distribution which can be broad, narrow or truncated, while still comprising ST2S wherein the average of the distribution is about 2.


Other anionic surfactants suitable for use in the personal cleansing compositions are the succinates, examples of which include disodium N-octadecylsulfosuccinnate; disodium lauryl sulfosuccinate; diammonium lauryl sulfosuccinate; tetrasodium N-(1,2-dicarboxyethyl)-N-octadecylsulfosuccinnate; diamyl ester of sodium sulfosuccinic acid; dihexyl ester of sodium sulfosuccinic acid; and dioctyl esters of sodium sulfosuccinic acid.


Other examples of anionic surfactants for use in the personal cleansing compositions include sodium lauryl sarcosinate, sodium lauroyl sarcosinate, lauryl sarcosine, cocoyl sarcosine, alkyl phosphate esters, ethoxylated alkyl phosphate esters, and combinations thereof.


Often, SLE1S, SLE2S, and SLE3S are combined with SLS in personal care compositions. Examples of personal care compositions can comprise less than about 2% SLS, alternatively less than about 1% SLS, alternatively less than about 0.5% SLS, alternatively less than about 0.1% SLS, alternatively less than about 0.05% SLS, alternatively between about 0.01% SLS and about 0.05% SLS, alternatively about 0% SLS.


Often, SLE1S, SLE2S, and SLE3S or ALE1S, ALE2S, and ALE3S are combined with ALS in personal care compositions. Examples of personal care compositions can comprise less than about 2% ALS, alternatively less than about 1% ALS, alternatively less than about 0.5% ALS, alternatively less than about 0.1% ALS, alternatively less than about 0.05% ALS, alternatively between about 0.01% ALS and about 0.05% ALS, alternatively about 0% ALS.


Cosurfactants


The personal care compositions can also comprise a cosurfactant. Cosurfactants can comprise from 0.1% to 20%, from about 2% to about 10%, or from about 2% to about 5% by weight of the personal care composition. Cosurfactants may also comprise more than 20% by weight of the personal care composition. Cosurfactants can comprise amphoteric surfactants, zwitterionic surfactants, non-ionic surfactants, and mixtures thereof.


Examples of amphoteric/zwitterionic surfactants are betaine surfactants. Examples of betaine surfactants useful herein include the high alkyl betaines such as coco dimethyl carboxymethyl betaine, lauryl dimethyl carboxymethyl betaine, lauryl dimethyl alpha-carboxyethyl betaine, cetyl dimethyl carboxymethyl betaine, lauryl bis-(2-hydroxy-ethyl) carboxy methyl betaine, stearyl bis-(2-hydroxy-propyl) carboxymethyl betaine, oleyl dimethyl gamma-carboxypropyl betaine, lauryl bis-(2-hydroxypropyl) alpha-carboxyethyl betaine, etc. Other betaines are the sulfobetaines which may be represented by coco dimethyl sulfopropyl betaine, stearyl dimethyl sulfopropyl betaine, lauryl dimethyl sulfoethyl betaine, lauryl bis-(2-hydroxy-ethyl) sulfopropyl betaine and the like; amido betaines and amidosulfobetaines, wherein an RCONH(CH2)x radical is attached to the nitrogen atoms of the betaine are also useful in this invention. A preferred betaine is cocamidopropyl betaine.


Other useful surfactants include the amphoacetates such as sodium laurylamphoacetate and nonionic surfactants like, for example, glucosides such as decyl glucosides, monoglycerides such as glyceryl monolaurate, alkanolamides such as cocomonoethanolamide, and glyceryl ethers such as PEG-80 glyceryl cocoate.


Water


The liquid personal cleansing compositions of the present invention can also contain from about 20% to about 95%, from about 40% to about 90%, from about 60% to about 90%, and from about 70% to about 90% water by weight of the compositions.


Modifiers


The personal care compositions can further comprise a viscosity modifier for modifying the viscosity of the personal care composition. Such concentrations can range, for example, from about 0.1% to about 10%, from about 0.3% to about 5.0%, or from 0.5% to 3% by weight of the personal care compositions.


Non limiting examples of viscosity modifiers useful herein include inorganic salts. Examples of inorganic salts useful herein magnesium nitrate, trimagnesium phosphate, calcium chloride, sodium carbonate, sodium chloride, sodium aluminum sulfate, disodium phosphate, sodium polymetaphosphate, sodium magnesium succinate, sodium sulfate, sodium tripolyphosphate, aluminum sulfate, aluminum chloride, aluminum chlorohydrate, aluminum-zirconium trichlorohydrate, aluminum-zirconium trichlorohydrate glycine complex, zinc sulfate, ammonium chloride, ammonium phosphate, ammonium sulfate, calcium acetate, calcium nitrate, calcium phosphate, calcium sulfate, ferric sulfate, magnesium chloride, magnesium sulfate, alkyl ether sulfate, mixtures thereof, and the like.


Viscosity modifiers can also include polymers. Non limiting examples of polymers include cellulose derivatives and modified cellulose polymers such as methyl cellulose, ethyl cellulose, hydroxyethyl cellulose, hydroxypropyl methyl cellulose, nitro cellulose, sodium cellulose sulfate, sodium carboxymethyl cellulose, crystalline cellulose, cellulose powder, polyvinylpyrrolidone, polyvinyl alcohol, guar gum, hydroxypropyl guar gum, xanthan gum, arabia gum, tragacanth, galactan, carob gum, guar gum, karaya gum, carrageenan, pectin, agar, quince seed (Cydonia oblonga Mill), starch (rice, corn, potato, wheat), algae colloids (algae extract), microbiological polymers such as dextran, succinoglucan, pulleran, starch-based polymers such as carboxymethyl starch, methylhydroxypropyl starch, alginic acid-based polymers such as sodium alginate, alginic acid propylene glycol esters, acrylate polymers such as sodium polyacrylate, polyethylacrylate, polyacrylamide, polyethyleneimine, and inorganic water soluble material such as bentonite, aluminum magnesium silicate, laponite, hectonite, and anhydrous silicic acid.


Polyol


The personal care compositions can further comprise polyols. Such concentrations can range, for example, from about 0.1% to about 10%, from about 0.3% to about 5.0%, or from 0.5% to 3% by weight of the personal care compositions.


Non limiting examples of polyols useful herein include glycerin, sorbitol, propylene glycol, butylene glycol, hexylene glycol, ethoxylated glucose, 1,2-hexane diol, hexanetriol, dipropylene glycol, trehalose, diglycerin, maltitol, maltose, glucose, fructose, sodium chondroitin sulfate, sodium hyaluronate, sodium adenosin phosphate, sodium lactate, pyrrolidone carbonate, glucosamine, cyclodextrin, and mixtures thereof.


Other Optional Ingredients


The personal care compositions can also include other personal care adjunct ingredients that may modify the physical, chemical, cosmetic or aesthetic characteristics of the compositions or serve as “active” components when deposited on the skin. Non limiting examples of such adjunct ingredients include preservatives (e.g., propyl paraben), deodorants, antimicrobials, fragrances, deodorant perfumes, coloring agents or dyes, thickeners, sensates, sunscreens, surfactants or emulsifiers, gellants or other suspending agents, pH modifiers, co-solvents or other additional solvents, emollients, pharmaceutical actives, vitamins, and combinations thereof. Other non-limiting examples of adjunct ingredients include: enzymes, abrasives, skin exfoliating agents, absorbents, aesthetic components such as fragrances, pigments, colorings/colorants, essential oils, skin sensates, astringents, etc. (e.g., clove oil, menthol, camphor, eucalyptus oil, eugenol, menthyl lactate, witch hazel distillate), anti-acne agents (e.g., resorcinol, sulfur, salicylic acid, erythromycin, zinc, etc.), anti-caking agents, antifoaming agents, additional antimicrobial agents (e.g., iodopropyl butylcarbamate), antioxidants, binders, biological additives, buffering agents, bulking agents, chelating agents, chemical additives, colorants, cosmetic astringents, cosmetic biocides, denaturants, drug astringents, external analgesics, film formers or materials, e.g., polymers, for aiding the film-forming properties and substantivity of the composition (e.g., copolymer of eicosene and vinyl pyrrolidone), humectants, opacifying agents, pH adjusters, propellants, reducing agents, sequestrants, skin bleaching agents (or lightening agents) (e.g., hydroquinone, kojic acid, ascorbic acid, magnesium ascorbyl phosphate, ascorbyl glucosamine), skin-conditioning agents (humectants, including miscellaneous and occlusive), skin soothing and/or healing agents (e.g., panthenol and derivatives (e.g., ethyl panthenol), aloe vera, pantothenic acid and its derivatives, allantoin, bisabolol, and dipotassium glycyrrhizinate), skin treating agents, including agents for preventing, retarding, arresting, and/or reversing skin wrinkles (e.g., alpha-hydroxy acids such as lactic acid and glycolic acid and beta-hydroxy acids such as salicylic acid), thickeners, hydrocolloids, particular zeolites, and vitamins and derivatives thereof (e.g. tocopherol, tocopherol acetate, beta carotene, retinoic acid, retinol, retinoids, retinyl palmitate, niacin, niacinamide, panthenol, and the like).


Test Methods


The viscosity of the personal care composition can be measured using a digital Brookfield Viscometer (model RVDVII) with a CPE-41 spindle with temperature control. The viscosity is measured at 25° C., with a 1 mm gap (distance between the rotating spindle and the wall of the RVDVII), at a shear rate of 1 RPM (rotations per minute). Each measurement is taken for a period of two minutes to allow for the collection of enough data points to determine the average viscosity of the product (i.e. the spindle rotates at 1 rpm for 2 minutes).


The ratio of G″ to G′ (i.e. G″÷G′) is referred to as the tan delta. To measure the viscous modulus (G″) and elastic modulus (G′) of a personal care composition, an Advanced Rheometer, AR G2 Rheometer (TA Instruments, Del., USA) equipped with a 1 degree cone upper geometry having a diameter of 40 mm and a flat plate lower geometry equipped with a peltier heating/cooling mechanism to control temperature is used. Measurements are conducted by placing approximately 1 gram of the personal care composition onto the lower test geometry and lowering the upper geometry to the desired gap of about 27 micrometers, wiping away any excess of the personal care composition to create an even surface around the edges of the upper and lower geometries. The test is conducted over a frequency range of 0.01 to 100 radians per second, collecting 10 data points per decade, using a constant oscillatory stress of 0.1 Pa and a set temperature of 10° C. or 25° C.


EXAMPLES

Comparative Examples C-1 through C-16 and Inventive Examples I-1 through I-15 were prepared by the following method. First, all of the ingredients except for NaCl are mixed for each respective personal care composition using a Speed Mixer (Model No. DAC 400 FVZ by Hauschild) for one minute at 2000 rpm. The one minute interval should be sufficient to achieve a homogenous solution. Next, the solution containing NaCl is added and all ingredients are then remixed. The viscosity and tan delta were then measured for each example as described herein.


The compositions in Tables 1 and 2 depict the percentage of each ingredient, or solution, by weight of the personal care composition. Quantities are expressed as a percentage of the ingredient added including any inactive components contained in the ingredient. As an illustrative example only, a composition containing about 25% of the sodium laureth-3 sulfate ingredient by weight of the composition, indicates a composition containing about 7.0% active sodium laureth-3 sulfate by weight of the composition (25% ingredient by weight of the composition*28% active component of the ingredient=7.0% active sodium laureth-3 sulfate by weight of the composition).










TABLE 1








Comparative Examples























Ingredient
C-1
C-2
C-3
C-4
C-5
C-6
C-7
C-8
C-9
C-10
C-11
C-12
C-13
C-14
C-15
C-16





Water
Q.S.
Q.S.
Q.S.
Q.S.
Q.S.
Q.S.
Q.S.
Q.S.
Q.S.
Q.S.
Q.S.
Q.S.
Q.S.
Q.S.
Q.S.
Q.S.


SLE3S (28% active)
23
30
23
23
28
23
30
30
30
23
23
23
23
28
23
22


CAPB (30% active)
3
12
3
3
4
3
12
12
12
3
3
3
3
4
3
3


SLS (29% active)
9

9
9
10
9



9
9
9
9
10
9
8


Sorbitol (70% active)
4.3


4.3
4.3
4.3



0
1.5
3
2
0
0
0


Glycerin


















Thixcin
0.5


0.5
0.5













Sodium Benzoate
0.25
0.25
0.25
0.25
0.25
0.25
0.25
0.25
0.25
0.25
0.25
0.25
0.25
0.25
0.25
0.25


Methyl-
0.033
0.033
0.033
0.033
0.033
0.033
0.033
0.033
0.033
0.033
0.033
0.033
0.033
0.033
0.033
0.033


chloroisothiazolinone/


















methylisothiaxolinone


















Fragrance
1
1.1
1
1
1
1
1
1
1
1
1
1
1
1
1
1


Na EDTA
0.1
0.1
0.1
0.1
0.1
0.1
0.1
0.1
0.1
0.1
0.1
0.1
0.1
0.1
0.1
0.1


HC Base (20% EDGS)
5


5














Euperlan (15% EDGS)





0.5












Polyuquat-10
0.1


0.1














JR 400


















Beads
0.2


0.2
0.1













Citric Acid
0.15
0.15
0.15
0.15
0.15
0.15
0.15
0.15
0.15
0.15
0.15
0.15
0.15
0.15
0.15
0.15


NaCl (20% active)
10
5
5
10
9.5
12.5
10
10
10
10
10
10
10
10
10
10


Skin Actives
0.01
0.02
0.01
0.01
0.01
0.01












Dyes


0.02


0.02












Styrene-Acrylates

0.75
















Minerals

0.02


0.1













Product Viscosity (cP)
7,552
5,428
5,256
7,550
7,300
10,000
6,500
7,000
6,250
7,500
8,000
8,000
8,900
5,700
6,200
6,000


Product Tan Delta
0.49
0.40
0.57
0.49
0.54
0.33
0.47
0.46
0.45
0.49
0.41
0.40
0.34
0.50
0.45
0.39


(25° C.)


















Product Tan Delta
0.23
0.30
0.20
0.23
0.25
0.08
0.18
0.17
0.24
0.23
0.17
0.21
0.19
0.25
0.17
0.14


(10° C.)

















TABLE 2








Inventive Examples















Ingredient
I-1
I-2
I-3
I-4
I-5
I-6
I-7
I-8





Water
Q.S.
Q.S.
Q.S.
Q.S.
Q.S.
Q.S.
Q.S.
Q.S.


SLE3S (28% active)
25
30
25
25
25
25
30
30


CAPB (30% active)
10
12
10
10
10
10
12
12


SLS (29% active)










Sorbitol (70% active)
4.3
4.3
8
8
4.3
4.3




Glycerin






1
2


Thixcin










Sodium Benzoate
0.25
0.25
0.25
0.25
0.25
0.25
0.25
0.25


Methylchloroisothiazolinone/
0.033
0.033
0.033
0.033
0.033
0.033
0.033
0.033


methylisothiaxolinone










Fragrance
0.3
1
0.3
0.3
1
0.3
1
1


Na EDTA
0.1
0.1
0.1
0.1
0.1
0.1
0.1
0.1


HC Base (20% EDGS)
3

3
3
3
3
2
2


Euperlan (15% EDGS)

1








Polyuquat-10
0.1

0.1
0.1

0.1




JR 400




0.1





Beads










Citric Acid
0.15
0.15
0.15
0.15
0.15
0.15
0.15
0.15


NaCl (20% active)
8.5
3.75
8.5
15
8.5
7.5
10
10


Skin Actives
0.01
0.01
0.01
0.01
0.01
0.01




Dyes
0.04
0.02
0.04
0.04
0.04
0.04




Styrene-Acrylates










Minerals










Product Viscosity (cP)
9,394
9,099
5,194
19,050
11,400
6,550
23,000
23,000


Product Tan Delta (25° C.)
0.49
0.42
0.55
0.61
0.42
0.53
0.30
0.30


Product Tan Delta (10° C.)
0.48
0.36
0.35
0.37
0.43
0.45
0.36
0.34














Inventive Examples
















Ingredient
I-9
I-10
I-11
I-12
I-13
I-14
I-15






Water
Q.S.
Q.S.
Q.S.
Q.S.
Q.S.
Q.S.
Q.S.



SLE3S
30
25
25
25
30
30
30



(28% active)










CAPB
12
8
8
8
12
12
12



(30% active)










SLS (29% active)










Sorbitol

1.5
3
4.5
0
0
0



(70% active)










Glycerin
3



1
2
3



Thixcin










Sodium Benzoate
0.25
0.25
0.25
0.25
0.25
0.25
0.25



Methylchloro-
0.033
0.033
0.033
0.033
0.033
0.033
0.033



isothiazolinone/










methyliso-










thiaxolinone










Fragrance
1
1
1
1
1
1
1



Na EDTA
0.1
0.1
0.1
0.1
0.1
0.1
0.1



HC Base
2



2
2
2



(20% EDGS)










Euperlan










(15% EDGS)










Polyuquat-10










JR 400










Beads










Citric Acid
0.15
0.15
0.15
0.15
0.15
0.15
0.15



NaCl (20% active)
10
10
10
10
2.5
2.5
2.5



Skin Actives










Dyes










Styrene-Acrylates










Minerals










Product
20,000
9,000
10,000
8,500
3,000
3,000
3,000



Viscosity (cP)










Product Tan
0.30
0.54
0.50
0.50
0.73
0.80
0.91



Delta (25° C.)










Product Tan
0.33
0.49
0.52
0.45
1.04
0.91
1.00



Delta (10° C.)









As shown in Table 1, Comparative Examples C-1, C-4 through C-6, and C-11 to C-13 illustrate personal care compositions containing SLS in combination with SLE3S (sodium laureth(3) sulfate), CAPB (cocamidopropyl betaine), and sorbitol. Comparative Examples C-2 and C-7 to C-9 illustrate a personal care composition containing SLE3S and CAPB, but not SLS or a polyol. Comparative Examples C-3, C-10, and C-14 through C-16 illustrate a personal care composition containing SLS, SLE3S, and CAPB, but not a polyol.


Inventive Examples I-1 through I-6, and I-10 through I-12 in Table 2, illustrate personal care compositions containing SLES, CAPB, and sorbitol but not SLS. Inventive Examples I-7 through I-9, and I-13 to I-15 illustrate personal care compositions containing SLES, CAPB and glycerin but not SLS. Inventive Examples I-10 to I-12 illustrate personal care compositions containing SLES, CAPB, and low amounts of sorbitol but not SLS.


Comparing Comparative Examples C-3 to C-4, it appears that the addition of sorbitol alone to personal care compositions containing SLS, SLE3S, and CAPB does not result in stable personal care compositions (i.e. personal care compositions having a tan delta greater than about 0.30 at about 10° C.). Comparing C-2 to C-3, it also appears that the removal of SLS from personal care compositions containing SLE3S and CAPB, but without a polyol, does not result in stable personal care compositions as the resulting composition failed to provide desired rheological properties sought by consumers. For example, C-2 was perceived as too gel-like and difficult to spread on the skin, and therefore not stable.


Finally, comparative Examples C-4 through C-6 illustrate that while increasing the concentration of the viscosity modifier NaCl in personal care compositions containing SLE3S, SLS, CAPB, and sorbitol can enhance the viscosity of the personal care compositions, the inclusion of the viscosity modifier alone does not result in a tan delta greater than 0.30 at about 10° C. for the personal care composition.


Surprisingly, comparing Inventive Examples I-1 to I-6 with Comparative Examples C-2, and C-7 through C-9, illustrate that the inclusion of sorbitol in personal care compositions containing SLE3S and CAPB but not SLS results in personal care compositions with a tan delta greater than 0.30 at about 10° C. The amount of sorbitol by weight of the personal care composition required to stabilize the personal care composition containing SLE3s and CAPB can be under 10% as shown in I-1 through I-6 or even in the range of only about 1.5% to about 4.5% as shown in I-10 through I-12. For example, comparing C-2 to I-2, the addition of approximately 3% sorbitol by weight of the personal care composition to the personal care composition containing SLE3S and CAPB but not SLS, increased the tan delta from about 0.30 at about 10° C. to about 0.36 at about 10° C.


The inclusion of glycerin in personal care compositions containing SLE3S and CAPB but not SLS also results in personal care compositions with a tan delta greater than 0.30 at about 10° C. as seen in Inventive Examples I-7 through I-9 through I-13. Comparing I-7 through I-9 with C-7 through C-9 shows the addition of just about 1% to about 3% glycerin by weight of the personal care composition to the personal care composition containing SLE3S and CAPB but not SLS results in an increase of the tan delta from a range of 0.18 to 0.24 to a range of 0.36 to 0.33.


Comparing I-3 to I-4, it also appears that the viscosity of the stable personal care composition containing SLE3S and CAPB but not SLS can be enhanced by increasing the concentration of the viscosity modifier, NaCl. By comparing I-13 to I-15 with I-7 to I-9, it is also apparent that the viscosity of the stable personal care composition can be enhanced by increasing the viscosity modifier while still retaining a tan delta of 0.30 or more for the personal care composition at 10° C.


The dimensions and values disclosed herein are not to be understood as being strictly limited to the exact numerical values recited. Instead, unless otherwise specified, each such dimension is intended to mean both the recited value and a functionally equivalent range surrounding that value. For example, a dimension disclosed as “40 mm” is intended to mean “about 40 mm.”


All documents cited in the Detailed Description of the Invention are, in relevant part, incorporated herein by reference; the citation of any document is not to be construed as an admission that it is prior art with respect to the present invention. To the extent that any meaning or definition of a term in this document conflicts with any meaning or definition of the same term in a document incorporated by reference, the meaning or definition assigned to that term in this document shall govern.


While particular embodiments of the present invention have been illustrated and described, it would be obvious to those skilled in the art that various other changes and modifications can be made without departing from the spirit and scope of the invention. It is therefore intended to cover in the appended claims all such changes and modifications that are within the scope of this invention.

Claims
  • 1. A liquid personal care composition comprising: i) a primary surfactant comprising an anionic surfactant not sodium lauryl sulfate or ammonium lauryl sulfate;ii) a secondary surfactant comprising a zwitterionic surfactant, an amphoteric surfactant, a non-ionic surfactant, or a combination thereof; andiii) a polyol which is sorbitol;wherein the personal care composition exhibits a tan delta of about 0.30 or more at 10° C.
  • 2. The personal care composition of claim 1, wherein the personal care composition is substantially free of non-ethoxylated alkyl sulfates.
  • 3. The personal care composition of claim 1, wherein the personal care composition is substantially free of sodium lauryl sulfate.
  • 4. The personal care composition of claim 1, further comprising a viscosity modifier selected from the group consisting of magnesium nitrate, trimagnesium phosphate, calcium chloride, sodium carbonate, sodium chloride, sodium aluminum sulfate, disodium phosphate, sodium polymetaphosphate, sodium magnesium succinate, sodium sulfate, sodium tripolyphosphate, aluminum sulfate, aluminum chloride, aluminum chlorohydrate, aluminum-zirconium trichlorohydrate, aluminum-zirconium trichlorohydrate glycine complex, zinc sulfate, ammonium chloride, ammonium phosphate, ammonium sulfate, calcium acetate, calcium nitrate, calcium phosphate, calcium sulfate, ferric sulfate, magnesium chloride, magnesium sulfate, alkyl ether sulfate, and mixtures thereof.
  • 5. The personal care composition according to claim 1, wherein the secondary surfactant comprises cocoamidopropyl betaine.
  • 6. The personal care composition of claim 5, wherein the cocoamidopropyl betaine comprises from about 2% to about 5% of the personal care composition by weight.
  • 7. The personal care composition according to claim 1, wherein the polyol comprises from about 0.5% to less than 10% by weight of the personal care composition.
  • 8. The personal care composition of claim 1, wherein the personal care composition comprises from about 0.5% to about 5.0% sorbitol by weight of the personal care composition.
  • 9. The personal care composition according to claim 1, wherein the primary surfactant comprises from about 5% to about 10% by weight of the personal care composition.
  • 10. The personal care composition according to claim 1, wherein the primary surfactant comprises from about 6.4% to about 10% by weight of the personal care composition.
  • 11. The personal care composition according to claim 1, wherein the primary surfactant comprises sodium laureth(n) sulfate, ammonium laureth(n) sulfate, sodium trideceth(n) sulfate, or ammonium trideceth(n) sulfate.
  • 12. The personal care composition according to claim 11, wherein the primary surfactant comprises sodium laureth(3) sulfate.
  • 13. The personal care composition according to claim 1, wherein the personal care composition exhibits a viscosity of about 5,000 cP or more at about 25° C.
  • 14. The personal care composition according to claim 1, wherein the personal care composition exhibits a tan delta of about 0.33 or more at about 10° C.
  • 15. The personal care composition according to claim 1, wherein the personal care composition exhibits a tan delta of about 0.35 or more at about 10° C.
  • 16. A liquid personal care composition comprising: i) a primary surfactant comprising sodium laureth (3) sulfate;ii) a secondary surfactant comprising a zwitterionic surfactant, an amphoteric surfactant, a non-ionic surfactant, or a combination thereof;iii) a viscosity modifier; andiv) sorbitol comprising from about 0.5% to less than 10% by weight of the personal care composition;wherein the personal care composition exhibits a tan delta of about 0.35 or more at about 10° C. and is substantially free of sodium lauryl sulfate.
US Referenced Citations (278)
Number Name Date Kind
5109127 Sekiguchi Apr 1992 A
5120464 Kamegai et al. Jun 1992 A
5352386 Rahman et al. Oct 1994 A
5352387 Rahman et al. Oct 1994 A
5358656 Humphreys et al. Oct 1994 A
5385685 Humphreys et al. Jan 1995 A
5393450 Shana'a Feb 1995 A
5447652 Nozaki et al. Sep 1995 A
5529712 Sano et al. Jun 1996 A
5529768 Pocalyko et al. Jun 1996 A
5632978 Moore et al. May 1997 A
5641813 Franklin et al. Jun 1997 A
5653970 Vermeer Aug 1997 A
5674511 Kacher et al. Oct 1997 A
5709852 Gopalkrishnan et al. Jan 1998 A
5716920 Glenn, Jr. et al. Feb 1998 A
5734029 Wulff et al. Mar 1998 A
5854199 Oshimura et al. Dec 1998 A
5854293 Glenn, Jr. Dec 1998 A
5858343 Szymczak Jan 1999 A
5858938 Glenn, Jr. et al. Jan 1999 A
5863521 Schaefer et al. Jan 1999 A
5869070 Dixon et al. Feb 1999 A
5880076 Vermeer Mar 1999 A
5905062 Elliott et al. May 1999 A
5919748 Noguchi et al. Jul 1999 A
5928657 Simon Jul 1999 A
5929019 Puvvada et al. Jul 1999 A
5932528 Glenn, Jr. et al. Aug 1999 A
5942477 Giret et al. Aug 1999 A
5961992 Ilardi et al. Oct 1999 A
5965502 Balzer Oct 1999 A
5968491 Richardson Oct 1999 A
5968496 Linares et al. Oct 1999 A
5976520 Babinski et al. Nov 1999 A
5994280 Giret et al. Nov 1999 A
6028043 Glenn, Jr. et al. Feb 2000 A
6033680 Dixon et al. Mar 2000 A
6057275 Fair et al. May 2000 A
6107261 Taylor et al. Aug 2000 A
6121214 Exner et al. Sep 2000 A
6126954 Tsaur Oct 2000 A
6194364 Glenn, Jr. Feb 2001 B1
6277797 Glenn, Jr. et al. Aug 2001 B1
6306805 Bratescu et al. Oct 2001 B1
6322799 Ilardi et al. Nov 2001 B1
6329331 Aronson et al. Dec 2001 B1
6329353 Dalrymple et al. Dec 2001 B1
6352689 Szymczak Mar 2002 B1
6358493 Birkel et al. Mar 2002 B1
6387857 Chambers et al. May 2002 B2
6395701 Connor et al. May 2002 B1
6407044 Dixon Jun 2002 B2
6432896 Inaba et al. Aug 2002 B1
6444629 Elliott et al. Sep 2002 B1
6475474 Ricca Nov 2002 B1
6489274 LeGrow et al. Dec 2002 B1
6506713 Slavtcheff et al. Jan 2003 B1
6506714 Soriano et al. Jan 2003 B1
6525034 Dalrymple et al. Feb 2003 B2
6551971 Inaba et al. Apr 2003 B2
6566313 Hohenstein et al. May 2003 B1
6569439 Stier May 2003 B1
6602845 Connor et al. Aug 2003 B2
6624126 Kasuga et al. Sep 2003 B1
6641825 Scholz et al. Nov 2003 B2
6645511 Aronson et al. Nov 2003 B2
6660285 Ricca Dec 2003 B2
6692754 Makimoto et al. Feb 2004 B1
6696067 Brandt et al. Feb 2004 B2
6699824 Dawson et al. Mar 2004 B1
6706679 Bergeron et al. Mar 2004 B1
6716440 Aronson et al. Apr 2004 B2
6797683 Shana'a et al. Sep 2004 B2
6821942 Sebillotte-Arnaud et al. Nov 2004 B2
6849584 Geary et al. Feb 2005 B2
6855677 Matsumoto et al. Feb 2005 B1
6903057 Tsaur Jun 2005 B1
6905694 Modi Jun 2005 B1
6906016 Tsaur Jun 2005 B1
6916777 Connor et al. Jul 2005 B2
6927201 Hsu et al. Aug 2005 B2
6949502 Trinh et al. Sep 2005 B2
6977238 Wetzel et al. Dec 2005 B1
7041627 Kruse et al. May 2006 B2
7045491 Hourigan May 2006 B2
7138365 Murayama Nov 2006 B2
7186674 Guillou et al. Mar 2007 B2
7211273 Hsu May 2007 B2
7223799 Sakiguchi et al. May 2007 B2
7259131 Fan et al. Aug 2007 B2
7268106 Arai Sep 2007 B2
7279456 Dufay et al. Oct 2007 B2
7288616 Tamareselvy et al. Oct 2007 B2
7297667 Potechin et al. Nov 2007 B2
7297717 Iwai et al. Nov 2007 B2
7318929 Schieferstein et al. Jan 2008 B2
7332467 Schneiderman et al. Feb 2008 B2
7354891 Arai Apr 2008 B2
7455848 Hessefort et al. Nov 2008 B2
7488841 Yamawaki et al. Feb 2009 B2
7504370 Matsumoto et al. Mar 2009 B2
7560125 Ananthapadmanabhan et al. Jul 2009 B2
7566448 Becker et al. Jul 2009 B2
7582592 Yamamoto et al. Sep 2009 B2
7649047 Tamareselvy et al. Jan 2010 B2
7655744 Miyanaga Feb 2010 B2
7670999 Sebillotte-Arnaud et al. Mar 2010 B2
7700123 Sawaki et al. Apr 2010 B2
7704932 Evans et al. Apr 2010 B2
7713520 Sakuta May 2010 B2
7737103 Hloucha et al. Jun 2010 B2
7776318 Bissey-Beugras et al. Aug 2010 B2
7829070 Nguyen-Kim et al. Nov 2010 B2
7858567 Yamamoto et al. Dec 2010 B2
7863479 Tropsch et al. Jan 2011 B2
7879780 Tsaur Feb 2011 B2
7902135 Roso et al. Mar 2011 B2
7915208 Roso et al. Mar 2011 B2
7947260 Tobita May 2011 B2
7981851 Luciow et al. Jul 2011 B2
8071115 Sawaki et al. Dec 2011 B2
8076277 Luciow et al. Dec 2011 B2
8105691 Takeuchi et al. Jan 2012 B2
8110533 Tsaur Feb 2012 B1
8232321 Ohmori et al. Jul 2012 B2
8277786 Yang et al. Oct 2012 B2
8343520 Seigneurin et al. Jan 2013 B2
8361448 Johnson et al. Jan 2013 B2
8388939 Fournial et al. Mar 2013 B2
8394500 Beumer et al. Mar 2013 B2
8404258 Oguchi et al. Mar 2013 B2
9463151 Souda et al. Oct 2016 B2
20010044393 Peterson, Jr. et al. Nov 2001 A1
20010056049 Aronson et al. Dec 2001 A1
20020006882 Loffler et al. Jan 2002 A1
20020006883 Dixon Jan 2002 A1
20020010109 Chambers et al. Jan 2002 A1
20020010113 Kilpatrick-Liverman et al. Jan 2002 A1
20020051819 Kuhner et al. May 2002 A1
20020072483 Barresi et al. Jun 2002 A1
20020193266 Matsumoto et al. Dec 2002 A1
20030003069 Carson et al. Jan 2003 A1
20030064042 Bergquist et al. Apr 2003 A1
20030086892 Klug et al. May 2003 A1
20030100457 Ariotto et al. May 2003 A1
20030175232 Elliott et al. Sep 2003 A1
20030211057 Majeti et al. Nov 2003 A1
20030236180 Connor et al. Dec 2003 A1
20040028711 Uchida et al. Feb 2004 A1
20040033913 Dahms et al. Feb 2004 A1
20040042986 Meyer et al. Mar 2004 A1
20040043045 Seipel et al. Mar 2004 A1
20040048758 Zhang et al. Mar 2004 A1
20040052754 West et al. Mar 2004 A1
20040076654 Vinson et al. Apr 2004 A1
20040097472 West et al. May 2004 A1
20040115230 Divone et al. Jun 2004 A1
20040116539 Biercevicz et al. Jun 2004 A1
20040146540 Ueda et al. Jul 2004 A1
20040161482 Kawada et al. Aug 2004 A1
20040197361 Oguchi et al. Oct 2004 A1
20040219125 Yoneda et al. Nov 2004 A1
20040234484 Peffly et al. Nov 2004 A1
20040235702 Hawkins Nov 2004 A1
20040241124 Lannibois-Drean et al. Dec 2004 A1
20040266656 Sakurai Dec 2004 A1
20050008601 Ariotto et al. Jan 2005 A1
20050042261 Hasenoehrl et al. Feb 2005 A1
20050096249 Jonas et al. May 2005 A1
20050153869 Connor et al. Jul 2005 A1
20050154180 Hessefort et al. Jul 2005 A1
20050192189 Wagner et al. Sep 2005 A1
20050201965 Kuhlman et al. Sep 2005 A1
20050227902 Erazo-Majewicz et al. Oct 2005 A1
20050256313 Norenberg et al. Nov 2005 A1
20050276829 Stella et al. Dec 2005 A1
20050277568 Keenan et al. Dec 2005 A1
20050296950 Chrisstoffels et al. Dec 2005
20060009368 Norenberg et al. Jan 2006 A1
20060019847 Fan et al. Jan 2006 A1
20060051430 Arata et al. Mar 2006 A1
20060062751 Sato et al. Mar 2006 A1
20060073110 Modi Apr 2006 A1
20060079418 Wagner et al. Apr 2006 A1
20060079420 Wagner et al. Apr 2006 A1
20060083761 Yoshimi et al. Apr 2006 A1
20060088495 Harichian et al. Apr 2006 A1
20060089286 Chakrabarty et al. Apr 2006 A1
20060093689 Kawada et al. May 2006 A1
20060100115 Sakurai et al. May 2006 A1
20060115440 Arata et al. Jun 2006 A1
20060116305 Yamato et al. Jun 2006 A1
20060122322 Chrisstoffels et al. Jun 2006 A1
20060134045 Cao et al. Jun 2006 A1
20060134047 Bakeev et al. Jun 2006 A1
20060142174 Fukuda et al. Jun 2006 A1
20060160713 Sekine et al. Jul 2006 A1
20060165639 Gauweiler et al. Jul 2006 A1
20060183662 Crotty et al. Aug 2006 A1
20060189495 LiBrizzi et al. Aug 2006 A1
20060228319 Vona, Jr. et al. Oct 2006 A1
20070027050 Crotty et al. Feb 2007 A1
20070081953 Dahms Apr 2007 A1
20070105746 Dahms May 2007 A1
20070134176 Fukui et al. Jun 2007 A1
20070172441 Takeda et al. Jul 2007 A1
20070202071 Morvan et al. Aug 2007 A1
20070212320 Demitz et al. Sep 2007 A1
20070213243 Yao et al. Sep 2007 A1
20070243144 Takagaki Oct 2007 A1
20070243241 Lin et al. Oct 2007 A1
20070264204 Noor et al. Nov 2007 A1
20070274942 Morvan et al. Nov 2007 A1
20070286832 Clapp et al. Dec 2007 A1
20080031842 Kuhlman et al. Feb 2008 A1
20080031845 Stella et al. Feb 2008 A1
20080075684 Barg et al. Mar 2008 A1
20080108535 Aubrun-Sonneville May 2008 A1
20080124295 Duranton et al. May 2008 A1
20080169215 Tanaka et al. Jul 2008 A1
20080171794 Yamamoto et al. Jul 2008 A1
20080193404 Lange et al. Aug 2008 A1
20080214776 Llosas et al. Sep 2008 A1
20080214850 Llosas et al. Sep 2008 A1
20080233061 Gates et al. Sep 2008 A1
20080234172 McGee et al. Sep 2008 A1
20080255015 Beilfuss et al. Oct 2008 A1
20080299054 Chandar et al. Dec 2008 A1
20090062406 Loffler Mar 2009 A1
20090069522 Hessefort et al. Mar 2009 A1
20090081137 Nguyen Kim et al. Mar 2009 A1
20090093388 Yamawaki et al. Apr 2009 A1
20090197791 Balastre et al. Aug 2009 A1
20090214608 Monin et al. Aug 2009 A1
20090238769 Joziak et al. Sep 2009 A1
20090239776 Myers Sep 2009 A1
20090280071 Kumar et al. Nov 2009 A1
20090297462 Hessefort et al. Dec 2009 A1
20090305929 Luciow et al. Dec 2009 A1
20100008884 Brandt et al. Jan 2010 A1
20100047300 Kaupp et al. Feb 2010 A1
20100061956 Seigneurin et al. Mar 2010 A1
20100062961 Post et al. Mar 2010 A1
20100075881 Tsaur Mar 2010 A1
20100075882 Ohmori et al. Mar 2010 A1
20100098646 Carnali et al. Apr 2010 A1
20100120645 Fares et al. May 2010 A1
20100197543 Yamato et al. Aug 2010 A1
20100222305 West et al. Sep 2010 A1
20100234260 Sekine et al. Sep 2010 A1
20100254928 Yamazaki et al. Oct 2010 A1
20100256031 Wu et al. Oct 2010 A1
20100261670 West et al. Oct 2010 A1
20100311628 Librizzi et al. Dec 2010 A1
20100317555 Araki et al. Dec 2010 A1
20110033398 Cauvin et al. Feb 2011 A1
20110082105 Fevola et al. Apr 2011 A1
20110110874 Tanaka et al. May 2011 A1
20110150818 Canfield et al. Jun 2011 A1
20110152150 Bernard Jun 2011 A1
20110155165 Yamato et al. Jun 2011 A1
20110230380 Holzhauer et al. Sep 2011 A1
20120003338 Myers Jan 2012 A1
20120009127 Dasgupta et al. Jan 2012 A1
20120009285 Wei et al. Jan 2012 A1
20120014885 Collier et al. Jan 2012 A1
20120046210 Patel et al. Feb 2012 A1
20120070399 Jegou Mar 2012 A1
20120071568 Sugiyama et al. Mar 2012 A1
20120077880 Quan et al. Mar 2012 A1
20120077881 Quan et al. Mar 2012 A1
20120101172 Beutler et al. Apr 2012 A1
20120114573 Amalric et al. May 2012 A1
20120145171 Ananthapadmanabhan et al. Jun 2012 A1
20120183590 Seigneurin et al. Jul 2012 A1
20120183591 Dahms Jul 2012 A1
20120322712 Yao et al. Dec 2012 A1
Foreign Referenced Citations (66)
Number Date Country
101703454 May 2010 CN
19646413 May 1998 DE
19705862 Jun 1998 DE
10007321 Aug 2001 DE
353735 Feb 1990 EP
409005 Jan 1991 EP
473502 Mar 1992 EP
485212 May 1992 EP
493927 Jul 1992 EP
530866 Mar 1993 EP
531684 Mar 1993 EP
559375 Sep 1993 EP
560322 Sep 1993 EP
0 681 832 Nov 1995 EP
706791 Apr 1996 EP
853941 Jul 1998 EP
884380 Dec 1998 EP
1352644 Oct 2003 EP
1422288 May 2004 EP
1661976 May 2006 EP
1672054 Jun 2006 EP
2042216 Apr 2009 EP
2455063 May 2012 EP
2843971 May 2004 FR
2290551 Jan 1996 GB
2297761 Aug 1996 GB
2297975 Aug 1996 GB
05208905 Aug 1993 JP
06016523 Jan 1994 JP
08020525 Jan 1996 JP
2000290148 Oct 2000 JP
2001139456 May 2001 JP
2001140000 May 2001 JP
2002265990 Sep 2002 JP
2004155716 Jun 2004 JP
2005015359 Jan 2005 JP
2006028278 Feb 2006 JP
2006249124 Sep 2006 JP
2006299163 Nov 2006 JP
2009221121 Oct 2009 JP
5183859 Apr 2013 JP
2008035821 Apr 2008 KR
WO9205240 Apr 1992 WO
WO9417783 Aug 1994 WO
WO9418292 Aug 1994 WO
WO9423695 Oct 1994 WO
WO9513355 May 1995 WO
WO9603974 Feb 1996 WO
WO9827938 Jul 1998 WO
WO9924546 May 1999 WO
WO9938489 Aug 1999 WO
WO9938490 Aug 1999 WO
WO9938491 Aug 1999 WO
WO0015180 Mar 2000 WO
WO0115659 Mar 2001 WO
WO0126620 Apr 2001 WO
WO0172262 Oct 2001 WO
WO03084501 Oct 2003 WO
WO2004004678 Jan 2004 WO
WO2004035012 Apr 2004 WO
WO2004064802 Aug 2004 WO
WO2005049782 Jun 2005 WO
WO2006083843 Aug 2006 WO
WO2009103576 Aug 2009 WO
WO2012078159 Jun 2012 WO
WO2012086847 Jun 2012 WO
Non-Patent Literature Citations (3)
Entry
International Search Report and Written Opinion of the International Searching Authority mailed Feb. 5, 2014, PCT/US2013/067159, 17 pages.
Compositions with Beneficial Properties for Consumers, Ip.Com Journal, Oct. 21, 2008, 35 pages.
Disinfectant Concentrates as Additives in Various Compositions and Uses, IP.com Journal, Mar. 20, 2008, 68 pages.
Related Publications (1)
Number Date Country
20140121268 A1 May 2014 US
Provisional Applications (1)
Number Date Country
61719738 Oct 2012 US